SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-237875
Filing Date
2021-08-05
Accepted
2021-08-05 17:03:14
Documents
4
Effectiveness Date
2021-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d206194ds8.htm S-8 58054
2 EX-5.1 d206194dex51.htm EX-5.1 8909
3 EX-23.2 d206194dex232.htm EX-23.2 1194
4 GRAPHIC g206194g44z82.jpg GRAPHIC 2511
  Complete submission text file 0001193125-21-237875.txt   72811
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258509 | Film No.: 211149309
SIC: 2836 Biological Products, (No Diagnostic Substances)